SE9003100D0 - Lipid formulation system - Google Patents

Lipid formulation system

Info

Publication number
SE9003100D0
SE9003100D0 SE9003100A SE9003100A SE9003100D0 SE 9003100 D0 SE9003100 D0 SE 9003100D0 SE 9003100 A SE9003100 A SE 9003100A SE 9003100 A SE9003100 A SE 9003100A SE 9003100 D0 SE9003100 D0 SE 9003100D0
Authority
SE
Sweden
Prior art keywords
lipid
matrix
particle forming
lipid particle
forming matrix
Prior art date
Application number
SE9003100A
Other languages
English (en)
Inventor
M Nicklasson
Original Assignee
Kabivitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab
Priority to SE9003100A priority Critical patent/SE9003100D0/sv
Publication of SE9003100D0 publication Critical patent/SE9003100D0/sv
Priority to IE324691A priority patent/IE62194B1/en
Priority to EP91919389A priority patent/EP0514506B1/en
Priority to PCT/SE1991/000639 priority patent/WO1992005771A1/en
Priority to CA002069760A priority patent/CA2069760C/en
Priority to DE69119400T priority patent/DE69119400T2/de
Priority to JP3516564A priority patent/JP2855594B2/ja
Priority to AU87105/91A priority patent/AU645143B2/en
Priority to ES91919389T priority patent/ES2088024T3/es
Priority to DK91919389.6T priority patent/DK0514506T3/da
Priority to AT91919389T priority patent/ATE137667T1/de
Priority to PT99113A priority patent/PT99113B/pt
Priority to NO921231A priority patent/NO304729B1/no
Priority to FI922452A priority patent/FI107696B/sv
Priority to US08/242,054 priority patent/US5665379A/en
Priority to GR960402032T priority patent/GR3020674T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Saccharide Compounds (AREA)
  • Fertilizers (AREA)
SE9003100A 1990-09-28 1990-09-28 Lipid formulation system SE9003100D0 (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE9003100A SE9003100D0 (sv) 1990-09-28 1990-09-28 Lipid formulation system
IE324691A IE62194B1 (en) 1990-09-28 1991-09-13 Lipid formulation systems
AT91919389T ATE137667T1 (de) 1990-09-28 1991-09-24 System auf basis einer lipidformulierung
JP3516564A JP2855594B2 (ja) 1990-09-28 1991-09-24 脂質粒子形成マトリックス及びその製造方法
DK91919389.6T DK0514506T3 (da) 1990-09-28 1991-09-24 Lipid-formuleringssystem
CA002069760A CA2069760C (en) 1990-09-28 1991-09-24 Lipid formulation system
DE69119400T DE69119400T2 (de) 1990-09-28 1991-09-24 System auf basis einer lipidformulierung
EP91919389A EP0514506B1 (en) 1990-09-28 1991-09-24 Lipid formulation system
AU87105/91A AU645143B2 (en) 1990-09-28 1991-09-24 Lipid formulation system
ES91919389T ES2088024T3 (es) 1990-09-28 1991-09-24 Sistema de formulacion de lipidos.
PCT/SE1991/000639 WO1992005771A1 (en) 1990-09-28 1991-09-24 Lipid formulation system
PT99113A PT99113B (pt) 1990-09-28 1991-09-27 Processo para a preparacao de matrizes que originam particulas de lipidos
NO921231A NO304729B1 (no) 1990-09-28 1992-05-26 Lipidpartikkeldannende matriks
FI922452A FI107696B (sv) 1990-09-28 1992-05-27 Lipidpartikelbildande matris och förfarande för dess framställning
US08/242,054 US5665379A (en) 1990-09-28 1994-05-13 Lipid particle forming matrix, preparation and use thereof
GR960402032T GR3020674T3 (en) 1990-09-28 1996-07-31 Lipid formulation system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003100A SE9003100D0 (sv) 1990-09-28 1990-09-28 Lipid formulation system

Publications (1)

Publication Number Publication Date
SE9003100D0 true SE9003100D0 (sv) 1990-09-28

Family

ID=20380490

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003100A SE9003100D0 (sv) 1990-09-28 1990-09-28 Lipid formulation system

Country Status (15)

Country Link
EP (1) EP0514506B1 (sv)
JP (1) JP2855594B2 (sv)
AT (1) ATE137667T1 (sv)
AU (1) AU645143B2 (sv)
CA (1) CA2069760C (sv)
DE (1) DE69119400T2 (sv)
DK (1) DK0514506T3 (sv)
ES (1) ES2088024T3 (sv)
FI (1) FI107696B (sv)
GR (1) GR3020674T3 (sv)
IE (1) IE62194B1 (sv)
NO (1) NO304729B1 (sv)
PT (1) PT99113B (sv)
SE (1) SE9003100D0 (sv)
WO (1) WO1992005771A1 (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260065A (en) * 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
SE9200952D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
CN1091591C (zh) * 1994-02-04 2002-10-02 利珀克尔集团公司 亲脂载体制剂
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
SE9703691D0 (sv) 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
TR200101790T2 (tr) 1998-12-23 2001-10-22 Idea Ag. Yayılgan olmayan in vivo topik uygulamalar için geliştirilmiş formül
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
SE0201922D0 (sv) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
FR2868704B1 (fr) * 2004-04-07 2007-09-14 Ethypharm Sa Utilisation de lipides pour ameliorer la biodisponibilite de principes actifs proteiques en formulations injectables sous cutanees ou intra-musculaires
CN101084016A (zh) 2004-04-15 2007-12-05 克艾思马有限公司 能够容易穿透生物学障碍的组合物
CA2607738A1 (en) * 2005-04-28 2006-11-02 Galenica Technology Ab Pharmaceutical dosage forms comprising a lipid phase
ATE544444T1 (de) * 2005-10-11 2012-02-15 Yissum Res Dev Co Zusammensetzungen für die nasale abgabe
HUE033611T2 (en) 2008-09-17 2017-12-28 Chiasma Inc Pharmaceutical preparations and associated dosing procedures
CN101926757B (zh) 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
MA41462A (fr) 2015-02-03 2021-05-12 Chiasma Inc Méthode de traitement de maladies
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
IL308124A (en) * 2021-05-03 2023-12-01 Mcal Therapeutics Inc micro lipids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT8219012A0 (it) * 1982-01-06 1982-01-06 Ausonia Farma Srl Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.
EP0158441B2 (en) * 1984-03-08 2001-04-04 Phares Pharmaceutical Research N.V. Liposome-forming composition
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
ES2068197T3 (es) * 1987-01-27 1995-04-16 Vestar Inc Vehiculo de liberacion a base de fosfolipidos para ingredientes activos insolubles en agua.

Also Published As

Publication number Publication date
EP0514506A1 (en) 1992-11-25
PT99113A (pt) 1992-08-31
IE62194B1 (en) 1994-12-28
AU645143B2 (en) 1994-01-06
ATE137667T1 (de) 1996-05-15
JPH05503711A (ja) 1993-06-17
FI922452A0 (fi) 1992-05-27
FI922452A (fi) 1992-05-27
NO922084D0 (no) 1992-05-26
IE913246A1 (en) 1992-04-08
ES2088024T3 (es) 1996-08-01
FI107696B (sv) 2001-09-28
CA2069760A1 (en) 1992-03-29
JP2855594B2 (ja) 1999-02-10
AU8710591A (en) 1992-04-28
NO922084L (no) 1992-05-26
NO304729B1 (no) 1999-02-08
EP0514506B1 (en) 1996-05-08
DK0514506T3 (da) 1996-08-12
PT99113B (pt) 1999-02-26
DE69119400T2 (de) 1996-12-05
WO1992005771A1 (en) 1992-04-16
DE69119400D1 (de) 1996-06-13
CA2069760C (en) 1998-02-10
GR3020674T3 (en) 1996-10-31

Similar Documents

Publication Publication Date Title
DK0514506T3 (da) Lipid-formuleringssystem
DE3681755D1 (de) Wirkstofftraeger und diesen enthaltende arzneimittel.
FR2778406B1 (fr) Derives d'alpha-cetoamides, procede pour leur preparation, preparations pharmaceutiques les contenant, et leur utilisation en tant que medicaments anti-viraux
DE68920394T2 (de) Heterozyklische Verbindungen und Arzneimittel, die die Wirkung von Antikrebsmitteln verstärken, welche diese als wirksame Bestandteile enthalten.
AR011080A1 (es) Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento
IE54084B1 (en) Medicaments with a high degree of solubility and method for their production
FR2334359A1 (fr) Derives de l'isoquinoleine, leur preparation et medicaments contenant ces substances
ES2093440T3 (es) Derivados en la serie de la vitamina d con modificaciones en la posicion 20, procedimiento para su preparacion, productos intermedios para este procedimiento, preparados farmaceuticos que contienen estos derivados asi como su utilizacion para la preparacion de medicamentos.
IL108071A0 (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them
KR900005990A (ko) 차전자(psyllium)-함유 생성물
HUT52953A (en) Process for producing pharmaceutical compositions against allergy, particularly nasal drops
ES2058988T3 (es) Preparacion de medicamentos para el tratamiento sistemico de peces ornamentales y utiles.
Khan et al. Development of microencapsulation: A review of literature
KR970032872A (ko) 아세틸살리실산을 함유하는 피부 손상 처치용 약물
NO933323D0 (no) Naerings- og medikamentblandinger paa basis av kitosan for administrering til droevtyggere
IL82523A0 (en) Microbicidal compositions,their manufacture and drugs containing them
JPS5225015A (en) Process for preparing fine granular drugs
ATE28566T1 (de) Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin.
FR2676648B1 (fr) Nouvelles compositions, leur procede de preparation et leurs applications comme substance active de medicament antigrippal ou antiviral.
FR2732681B1 (fr) Derives de 10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one, leur preparation et les medicaments les contenant
BE862053A (fr) Peptides contenant de la phenylglycine utiles comme medicaments, procede pour leur preparation et compositions pharmaceutiques en contenant
BE874154A (fr) Derives de l'eburnamonine, leur preparation et medicaments contenant ces substances
KR100486794B1 (ko) 다른 상 운반체 사이에서 하나 또는 그 이상의 활성인자를 이동시키는 방법
KR920016104A (ko) 노인성 특발적 백내장 약제 제조를 위한 칼시토닌의 국소적용 용도 및 이의 약제학적 조성물
TH13351A (th) สารประกอบ